These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2554076)

  • 1. [Tumor markers and primary cancer of the liver].
    Ballesta AM; Molina R
    Med Clin (Barc); 1989 Sep; 93(7):256-8. PubMed ID: 2554076
    [No Abstract]   [Full Text] [Related]  

  • 2. In the new area of noninvasive markers of hepatocellular carcinoma.
    Paradis V; Bedossa P
    J Hepatol; 2007 Jan; 46(1):9-11. PubMed ID: 17112623
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological markers of hepatocellular carcinoma].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III and hepatocellular carcinoma.
    Lefrère JJ; Conard J; Lerable J; Samama M
    Thromb Haemost; 1989 Sep; 62(2):817. PubMed ID: 2554522
    [No Abstract]   [Full Text] [Related]  

  • 5. Glypican-3 as a serum marker for hepatocellular carcinoma.
    Capurro M; Filmus J
    Cancer Res; 2005 Jan; 65(1):372; author reply 372-3. PubMed ID: 15665316
    [No Abstract]   [Full Text] [Related]  

  • 6. A concise review of serum markers for hepatocellular cancer.
    Wright LM; Kreikemeier JT; Fimmel CJ
    Cancer Detect Prev; 2007; 31(1):35-44. PubMed ID: 17293059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of serum GPC3 as a tumor marker for hepatocellular carcinoma and malignant melanoma].
    Komori H; Beppu T; Baba H; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():833-6. PubMed ID: 20960882
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amplification of peripheral blood insulin-like growth factor II-mRNA and its clinical significance in the diagnosis of hepatocellular carcinoma].
    Yao DF; Dong ZZ; Liu YH; Zhao L; Huang JF; Meng XY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):695-6. PubMed ID: 14636457
    [No Abstract]   [Full Text] [Related]  

  • 10. The copper/zinc ratio in patients with hepatocellular carcinoma.
    Ebara M; Fukuda H; Saisho H
    J Gastroenterol; 2003; 38(1):104-5. PubMed ID: 12560932
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatoma-related gamma-glutamyl transferase in laboratory or clinical diagnosis of hepatocellular carcinoma.
    Yao DF; Dong ZZ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):9-11. PubMed ID: 17287158
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assay of decarboxy-prothrombin: its value in the diagnosis of hepatocellular carcinoma].
    Soulier JP; Lefrère JJ; Gozin D
    Ann Med Interne (Paris); 1988; 139(1):7-11. PubMed ID: 2834988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK; Khandekar JD
    Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract]   [Full Text] [Related]  

  • 15. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 16. [The prognostic value of focusylated alpha-fetoprotein measurement in liver cancer patients after surgery].
    Yin ZF; Wu MC; Yu ZQ
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):654-6. PubMed ID: 7539735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
    Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
    Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of serum tissue polypeptide specific antigen detection for primary hepatic cancer].
    Huang DR; Zuo Q; Cai HB; Zhang JY; Ji CY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):89-92. PubMed ID: 15684008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary liver cancer. Its epidemiological, clinical and biochemical characteristics].
    García Compeán D; Guzmán de la Garza FJ; Muñoz Espinoza LE; Valadez Castillo R; Martínez Flores AM; Fernández BA; Escobedo M; Barragán RF
    Rev Gastroenterol Mex; 1994; 59(1):17-22. PubMed ID: 8209148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Ono K; Kubo S
    J Hepatobiliary Pancreat Surg; 2006; 13(3):239-44. PubMed ID: 16708302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.